Durasert

EyePoint Pharmaceuticals Soaring On Wet AMD Study Results: Durasert ...

Our TKI | Vorolanib and Durasert E

Our TKI | Vorolanib and Durasert E

EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A 'Hold' At ...

EyePoint Pharmaceuticals: A Boon for Eye Disease Patients

Slide 4

Slide 5

Slide 12

EyePoint Pharmaceuticals: A Boon for Eye Disease Patients

EyePoint Pharmaceuticals: A Boon for Eye Disease Patients

EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy ...

Retinal Physician | PentaVision

EyePoint doses first patient in global phase 3 wet AMD trial of Duravyu

Slide 40

Slide 4

Slide 3

FDA to review pSivida's ocular drug-delivery system - Drug Delivery ...

EyePoint Pharmaceuticals on LinkedIn: #pk #durasert #ophthalmology # ...

Addressing the Gaps in Duration of Treatment for Age-Related Macular ...

How EyePoint Pharmaceuticals is developing sustained-release drug ...

EyePoint focused on long-lasting treatments for wet AMD and DR ...

EyePoint Pharmaceuticals’ wet AMD therapy hit primary endpoint in Phase ...

pSivida buys Icon Bioscience and rebrands as EyePoint Pharmaceuticals ...

EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy ...

EyePoint Pharmaceuticals announces positive interim 16-Week data for ...

EyePoint Pharmaceuticals: A Boon for Eye Disease Patients

EyePoint Pharmaceuticals: A Boon for Eye Disease Patients

EyePoint and Rallybio Announce Research Collaboration to Evaluate ...

EyePoint Pharmaceuticals logo in transparent PNG and vectorized SVG formats

EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy ...

Retina 2023 Presenting Companies | Ophthalmology Innovation Source

EyePoint Pharmaceuticals Announces Updated Positive Interim Safety and ...

EyePoint - BioSpace

EyePoint Pharmaceuticals, Inc. - AnnualReports.com

Slide 6

EyePoint Pharmaceuticals Announces Updated Positive Interim Safety and ...

EyePoint Pharmaceuticals logo in transparent PNG and vectorized SVG formats

How EyePoint Pharmaceuticals is developing sustained-release drug ...

EyePoint Pharmaceuticals Announces Updated Positive Interim Safety and ...

EyePoint, Rallybio collaboration to focus on sustained delivery of C5 ...

EyePoint Pharmaceuticals logo in transparent PNG and vectorized SVG formats

EyePoint Pharmaceuticals, Inc. Wields Latest Technology to Advance ...

EyePoint Pharmaceuticals unveils favorable topline results from phase 2 ...

EyePoint Pharmaceuticals doses first patient in Phase 2 VERONA Clinical ...

Slide 5

EyePoint Pharmaceuticals on LinkedIn: #wetamd #eyp1901 #durasert # ...

EyePoint Pharmaceuticals, Inc. - AnnualReports.com

EyePoint Pharmaceuticals announces first patient dosed in global Phase ...

EyePoint – EyePoint is committed to developing therapeutics to improve ...

EyePoint Pharmaceuticals, Inc. Stock — EYPT Overview — Roic AI

EyePoint Pharmaceuticals' Q4 2024 Earnings Call: Key Contradictions on ...

EyePoint begins dosing in second global Phase 3 LUCIA clinical trial of ...

Positive topline data reported in EyePoint's phase 2 wet AMD trial

Slide 34

Our Programs – EyePoint

EyePoint Pharmaceuticals releases an encouraging safety update for EYP ...

EyePoint Pharmaceuticals reports positive 16-week interim results from ...

Slide 5

贝达药业对外授权企业EyePoint获欧康维视投资1亿元|贝达药业|授权|投资|治疗|方案|眼科|-健康界

Slide 23

YUTIQ Approval Latest Step in EyePoint’s Transformation

Slide 37

Slide 24

Our Programs – EyePoint

EyePoint Pharmaceuticals 2025 Company Profile: Stock Performance ...

EyePoint长效疗法EYP-1901玻璃体内植入剂达到2期临床终点，治疗湿性AMD

EyePoint Pharmaceuticals announces positive topline data from Phase 2 ...

Buy EyePoint Pharmaceuticals stock | $EYPT Share Price | Lightyear

Slide 35

专注创新眼科产品，EyePoint Pharmaceuticals获2900万美元融资-动脉网

Slide 5

Our Programs – EyePoint

EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA ...

EYPT | EyePoint Pharmaceuticals, Inc. Common Stock Data, Price & News

Our Programs – EyePoint

Slide 10

EyePoint – EyePoint is committed to developing therapeutics to improve ...

Our Programs – EyePoint

Our Programs – EyePoint

Our Programs – EyePoint

EyePoint长效疗法EYP-1901玻璃体内植入剂达到2期临床终点，治疗湿性AMD

A Comprehensive Analysis of EyePoint Pharma's (EYPT) Stock Performance ...

Our Programs – EyePoint

Public Device & Biopharma Ophthalmology Company Showcase - pSivida | PPTX

EyePoint begins dosing in phase 3 DME trials for DURAVYU

Recent Advances in Ocular Drug Delivery Systems

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2025 Earnings Call ...

专注创新眼科产品，EyePoint公司获2900万美元融资_治疗

Our Programs – EyePoint

Our Programs – EyePoint

8-K

Tyrosine Kinase Inhibitors for Wet AMD and Diabetic Retinopathy ...

EyePoint TKI Program in Retinal Disease

EyePoint长效疗法EYP-1901玻璃体内植入剂达到2期临床终点，治疗湿性AMD

EyePoint Pharmaceuticals anuncia inicio ensayo clínico de fase 1 de EYP ...

EyePoint长效疗法EYP-1901玻璃体内植入剂达到2期临床终点，治疗湿性AMD

EyePoint – EyePoint is committed to developing therapeutics to improve ...

Slide 9

EyePoint Pharma announces first patient treatment in early-phase VERONA ...

8-K

Slide 14

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Director David R. Guyer ...

Slide 5

EyePoint Pharma announces first patient treatment in early-phase VERONA ...

Form 8-K - Current report

EyePoint Pharmaceuticals-EyePoint Pharmaceuticals, Inc.-企业详情-InvestGO ...

Our Programs – EyePoint

Our Programs – EyePoint

解码下一代爆款药的命门

Slide 35

8-K

DME

EyePoint Pharmaceuticals - OPHTHALMOLOGY FUTURES FORUMS

EyePoint Pharmaceuticals: A Significantly Overvalued Stock?

Buy EyePoint Pharmaceuticals Stock – EYPT Stock Quote Today ...

Biannual injection for AMD?

OIS Retina Sponsors 2026 | Ophthalmology Innovation Source

EyePoint fails to meet primary goal in phase 2 NPDR trial

Slide 24

8-K